Clinical Trials
60
Active:1
Completed:32
Trial Phases
4 Phases
Phase 2:2
Phase 3:18
Phase 4:12
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials
Not Applicable
25 (43.9%)Phase 3
18 (31.6%)Phase 4
12 (21.1%)Phase 2
2 (3.5%)Optimised Treatment for Hypertension Trial
Not Applicable
Not yet recruiting
- Conditions
- Hypertension
- First Posted Date
- 2025-04-20
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 120
- Registration Number
- NCT06935760
- Locations
- 🇦🇺
The George Institute for Global Health, Sydney, New South Wales, Australia
PRophylaxis Against Early VENTilator-associated Infections in Acute Brain Injury
Phase 3
Not yet recruiting
- Conditions
- All-cause MortalityQuality of LifeNeurological DisorderAcute Brain InjuryDisability, IntellectualVentilation, MechanicalIntensive Care Medicine
- Interventions
- Drug: Placebo comparator - no ceftriaxoneDrug: Ceftriaxone 2g diluted in >200ml 0.9%sodium chloride
- First Posted Date
- 2025-02-11
- Last Posted Date
- 2025-02-11
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 3100
- Registration Number
- NCT06819592
- Locations
- 🇦🇺
Nepean Hospital, Kingswood, New South Wales, Australia
🇦🇺St George Hospital, Kogarah, New South Wales, Australia
🇦🇺Royal North Shore Hospital, Sydney, New South Wales, Australia
The Fifth INTEnsive pReventing Secondary Injury in Acute Cerebral Haemorrhage Trial Within ACT-GLOBAL
Phase 3
Recruiting
- Conditions
- Intracerebral HemorrhageSpontaneous Intracerebral HemorrhageSupratentorial Intracerebral HaemorrhageAcute Intracerebral HaemorrhageAcute Stroke
- Interventions
- First Posted Date
- 2025-01-08
- Last Posted Date
- 2025-04-10
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 2000
- Registration Number
- NCT06763055
- Locations
- 🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
🇨🇳West China Hospital of Sichuan University, Chengdu, Sichuan, China
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR): a Randomized Controlled Trial
Phase 3
Not yet recruiting
- Conditions
- Subarachnoid HemorrhageSubarachnoid Hemorrhage, AneurysmalAneurysmal Subarachnoid HemorrhageHemorrhage, Aneurysmal Subarachnoid
- Interventions
- First Posted Date
- 2024-08-19
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 522
- Registration Number
- NCT06559072
- Locations
- 🇨🇳
Tianjin Medical University General Hospital, Tianjin, China
FLudrocortisone Administration in Aneurysmal Subarachnoid Haemorrhage
Phase 2
Not yet recruiting
- Conditions
- Aneurysmal Subarachnoid Hemorrhage
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-05-10
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- The George Institute
- Target Recruit Count
- 524
- Registration Number
- NCT06409364
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
No news found